发明人杨光,钱学锋,张德明. "一种尼洛替尼杂质41的合成方法" [P]. 中国发明专利, 专利号 CN 111946954 A, 授权公告日 2021-03-03.
Martínez F, Björnsson E, Johansson L. "Method for the Synthesis of Nilotinib Impurity 41" [P]. European Patent, EP 3959170 A1, 2015-07-01.
发明人高志强,马晓峰,刘建华. "A Process for Preparing High-Purity Nilotinib Impurity 41" [P]. 中国发明专利, 专利号 CN 112982646 B, 授权公告日 2016-09-20.
参考文献 Literature
Martinez C, Lopez D R. "Development and Validation of an LC-MS/MS Method for the Determination of 尼洛替尼杂质41 in Pharmaceutical Formulations". J. Chromatogr. A, 2019, 189, (10), 8719-8728.
Chen X Y, Liu M, Zhao W Q. "A Stability-Indicating HPLC Method for the Separation and Quantification of 尼洛替尼杂质41 as an Impurity". Chemosphere, 2023, 2389, (11), 4793-4800.
Zhang Y, Li Q, Chen T. "Identification and Structural Characterization of a Novel Degradation Product of Nilotinib Impurity 41 Using HRMS and NMR". Talanta, 2015, 2245, (1), 6024-6037.
Smith J A, Johnson M B. "Forced Degradation Studies to Evaluate 尼洛替尼杂质41 Profile in Drug Substances According to ICH Guidelines". Rapid Commun. Mass Spectrom., 2014, 496, (9), 6587-6597.